Test may help zero in on cancer

zero in on cancerAttempting to predict whether a prostate cancer tumor will be harmless or become a health threat—and thus, help guide treatment—is difficult. But Columbia University researchers have uncovered three genes that may help do just that. The study, appearing in Science Translational Medicine, analyzed samples from 43 men who were followed for a decade. All of them were considered to have low-risk prostate cancer.

Fourteen of the men—all of which were predicted by a gene test—went on to have tumors grow or become aggressive. The research showed that the genes were linked to suppressed tumor growth; when all three genes were active, prostate cancer was less likely to grow or become aggressive. More research is still needed.

Click Here for more information about prostate cancer prevention.